Guidelines for the use of human immunoglobulin therapy in patients with primary immunodeficiencies in Latin America
ABSTRACT: Antibodies are an essential component of the adaptative immune response and hold long-term memory of the immunological experiences throughout life. Antibody defects represent approximately half of the well-known primary immunodeficiencies requiring immunoglobulin replacement therapy. In th...
- Autores:
-
Condino Neto, Antonio
Costa Carvalho, B. T.
Grumach, A. S.
King, A.
Bezrodnik, L.
Oleastro, M.
Leiva, L.
Porras, O.
Espinosa Rosales, F. J.
Franco Restrepo, José Luis
Sorensen, R. U.
- Tipo de recurso:
- Article of investigation
- Fecha de publicación:
- 2014
- Institución:
- Universidad de Antioquia
- Repositorio:
- Repositorio UdeA
- Idioma:
- eng
- OAI Identifier:
- oai:bibliotecadigital.udea.edu.co:10495/21292
- Acceso en línea:
- http://hdl.handle.net/10495/21292
- Palabra clave:
- Inmunoglobulinas
Immunoglobulins
Enfermedades de Inmunodeficiencia Primaria
Primary Immunodeficiency Diseases
América Latina
Latin America
Immunoglobulin replacement therapy
Subcutaneous immunoglobulin
- Rights
- openAccess
- License
- http://creativecommons.org/licenses/by-nc-nd/2.5/co/
id |
UDEA2_8070b56ce3225a94dd843612a334ff70 |
---|---|
oai_identifier_str |
oai:bibliotecadigital.udea.edu.co:10495/21292 |
network_acronym_str |
UDEA2 |
network_name_str |
Repositorio UdeA |
repository_id_str |
|
dc.title.spa.fl_str_mv |
Guidelines for the use of human immunoglobulin therapy in patients with primary immunodeficiencies in Latin America |
title |
Guidelines for the use of human immunoglobulin therapy in patients with primary immunodeficiencies in Latin America |
spellingShingle |
Guidelines for the use of human immunoglobulin therapy in patients with primary immunodeficiencies in Latin America Inmunoglobulinas Immunoglobulins Enfermedades de Inmunodeficiencia Primaria Primary Immunodeficiency Diseases América Latina Latin America Immunoglobulin replacement therapy Subcutaneous immunoglobulin |
title_short |
Guidelines for the use of human immunoglobulin therapy in patients with primary immunodeficiencies in Latin America |
title_full |
Guidelines for the use of human immunoglobulin therapy in patients with primary immunodeficiencies in Latin America |
title_fullStr |
Guidelines for the use of human immunoglobulin therapy in patients with primary immunodeficiencies in Latin America |
title_full_unstemmed |
Guidelines for the use of human immunoglobulin therapy in patients with primary immunodeficiencies in Latin America |
title_sort |
Guidelines for the use of human immunoglobulin therapy in patients with primary immunodeficiencies in Latin America |
dc.creator.fl_str_mv |
Condino Neto, Antonio Costa Carvalho, B. T. Grumach, A. S. King, A. Bezrodnik, L. Oleastro, M. Leiva, L. Porras, O. Espinosa Rosales, F. J. Franco Restrepo, José Luis Sorensen, R. U. |
dc.contributor.author.none.fl_str_mv |
Condino Neto, Antonio Costa Carvalho, B. T. Grumach, A. S. King, A. Bezrodnik, L. Oleastro, M. Leiva, L. Porras, O. Espinosa Rosales, F. J. Franco Restrepo, José Luis Sorensen, R. U. |
dc.subject.decs.none.fl_str_mv |
Inmunoglobulinas Immunoglobulins Enfermedades de Inmunodeficiencia Primaria Primary Immunodeficiency Diseases América Latina Latin America |
topic |
Inmunoglobulinas Immunoglobulins Enfermedades de Inmunodeficiencia Primaria Primary Immunodeficiency Diseases América Latina Latin America Immunoglobulin replacement therapy Subcutaneous immunoglobulin |
dc.subject.proposal.spa.fl_str_mv |
Immunoglobulin replacement therapy Subcutaneous immunoglobulin |
description |
ABSTRACT: Antibodies are an essential component of the adaptative immune response and hold long-term memory of the immunological experiences throughout life. Antibody defects represent approximately half of the well-known primary immunodeficiencies requiring immunoglobulin replacement therapy. In this article, the authors review the current indications and therapeutic protocols in the Latin American environment. Immunoglobulin replacement therapy has been a safe procedure that induces dramatic positive changes in the clinical outcome of patients who carry antibody defects. |
publishDate |
2014 |
dc.date.issued.none.fl_str_mv |
2014 |
dc.date.accessioned.none.fl_str_mv |
2021-07-29T19:46:21Z |
dc.date.available.none.fl_str_mv |
2021-07-29T19:46:21Z |
dc.type.spa.fl_str_mv |
info:eu-repo/semantics/article |
dc.type.coarversion.fl_str_mv |
http://purl.org/coar/version/c_970fb48d4fbd8a85 |
dc.type.hasversion.spa.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.coar.spa.fl_str_mv |
http://purl.org/coar/resource_type/c_2df8fbb1 |
dc.type.redcol.spa.fl_str_mv |
https://purl.org/redcol/resource_type/ART |
dc.type.local.spa.fl_str_mv |
Artículo de investigación |
format |
http://purl.org/coar/resource_type/c_2df8fbb1 |
status_str |
publishedVersion |
dc.identifier.issn.none.fl_str_mv |
0301-0546 |
dc.identifier.uri.none.fl_str_mv |
http://hdl.handle.net/10495/21292 |
dc.identifier.doi.none.fl_str_mv |
10.1016/j.aller.2012.09.006 |
dc.identifier.eissn.none.fl_str_mv |
1578-1267 |
identifier_str_mv |
0301-0546 10.1016/j.aller.2012.09.006 1578-1267 |
url |
http://hdl.handle.net/10495/21292 |
dc.language.iso.spa.fl_str_mv |
eng |
language |
eng |
dc.relation.ispartofjournalabbrev.spa.fl_str_mv |
Allergol. immunopatol. |
dc.rights.spa.fl_str_mv |
info:eu-repo/semantics/openAccess |
dc.rights.uri.*.fl_str_mv |
http://creativecommons.org/licenses/by-nc-nd/2.5/co/ |
dc.rights.accessrights.spa.fl_str_mv |
http://purl.org/coar/access_right/c_abf2 |
dc.rights.creativecommons.spa.fl_str_mv |
https://creativecommons.org/licenses/by-nc-nd/4.0/ |
eu_rights_str_mv |
openAccess |
rights_invalid_str_mv |
http://creativecommons.org/licenses/by-nc-nd/2.5/co/ http://purl.org/coar/access_right/c_abf2 https://creativecommons.org/licenses/by-nc-nd/4.0/ |
dc.format.extent.spa.fl_str_mv |
16 |
dc.format.mimetype.spa.fl_str_mv |
application/pdf |
dc.publisher.spa.fl_str_mv |
Sociedad Española de Inmunología Clínica y Alergología Pediátrica Elsevier |
dc.publisher.group.spa.fl_str_mv |
Inmunodeficiencias Primarias |
dc.publisher.place.spa.fl_str_mv |
Murcia, España |
institution |
Universidad de Antioquia |
bitstream.url.fl_str_mv |
http://bibliotecadigital.udea.edu.co/bitstream/10495/21292/1/CondinoAntonio_2012_GuidelinesHumanImmunoglobulin.pdf http://bibliotecadigital.udea.edu.co/bitstream/10495/21292/2/license_rdf http://bibliotecadigital.udea.edu.co/bitstream/10495/21292/3/license.txt |
bitstream.checksum.fl_str_mv |
277ca5557c95acc04bd2e317b12a133b b88b088d9957e670ce3b3fbe2eedbc13 8a4605be74aa9ea9d79846c1fba20a33 |
bitstream.checksumAlgorithm.fl_str_mv |
MD5 MD5 MD5 |
repository.name.fl_str_mv |
Repositorio Institucional Universidad de Antioquia |
repository.mail.fl_str_mv |
andres.perez@udea.edu.co |
_version_ |
1812173171870138368 |
spelling |
Condino Neto, AntonioCosta Carvalho, B. T.Grumach, A. S.King, A.Bezrodnik, L.Oleastro, M.Leiva, L.Porras, O.Espinosa Rosales, F. J.Franco Restrepo, José LuisSorensen, R. U.2021-07-29T19:46:21Z2021-07-29T19:46:21Z20140301-0546http://hdl.handle.net/10495/2129210.1016/j.aller.2012.09.0061578-1267ABSTRACT: Antibodies are an essential component of the adaptative immune response and hold long-term memory of the immunological experiences throughout life. Antibody defects represent approximately half of the well-known primary immunodeficiencies requiring immunoglobulin replacement therapy. In this article, the authors review the current indications and therapeutic protocols in the Latin American environment. Immunoglobulin replacement therapy has been a safe procedure that induces dramatic positive changes in the clinical outcome of patients who carry antibody defects.COL001242616application/pdfengSociedad Española de Inmunología Clínica y Alergología PediátricaElsevierInmunodeficiencias PrimariasMurcia, Españainfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articlehttp://purl.org/coar/resource_type/c_2df8fbb1https://purl.org/redcol/resource_type/ARTArtículo de investigaciónhttp://purl.org/coar/version/c_970fb48d4fbd8a85info:eu-repo/semantics/openAccesshttp://creativecommons.org/licenses/by-nc-nd/2.5/co/http://purl.org/coar/access_right/c_abf2https://creativecommons.org/licenses/by-nc-nd/4.0/Guidelines for the use of human immunoglobulin therapy in patients with primary immunodeficiencies in Latin AmericaInmunoglobulinasImmunoglobulinsEnfermedades de Inmunodeficiencia PrimariaPrimary Immunodeficiency DiseasesAmérica LatinaLatin AmericaImmunoglobulin replacement therapySubcutaneous immunoglobulinAllergol. immunopatol.Allergologia et Immunopathologia245260423ORIGINALCondinoAntonio_2012_GuidelinesHumanImmunoglobulin.pdfCondinoAntonio_2012_GuidelinesHumanImmunoglobulin.pdfArtículo de investigaciónapplication/pdf1276782http://bibliotecadigital.udea.edu.co/bitstream/10495/21292/1/CondinoAntonio_2012_GuidelinesHumanImmunoglobulin.pdf277ca5557c95acc04bd2e317b12a133bMD51CC-LICENSElicense_rdflicense_rdfapplication/rdf+xml; charset=utf-8823http://bibliotecadigital.udea.edu.co/bitstream/10495/21292/2/license_rdfb88b088d9957e670ce3b3fbe2eedbc13MD52LICENSElicense.txtlicense.txttext/plain; charset=utf-81748http://bibliotecadigital.udea.edu.co/bitstream/10495/21292/3/license.txt8a4605be74aa9ea9d79846c1fba20a33MD5310495/21292oai:bibliotecadigital.udea.edu.co:10495/212922021-07-29 14:46:21.666Repositorio Institucional Universidad de Antioquiaandres.perez@udea.edu.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 |